Promontory Therapeutics

Developer of immunotherapeutics for the treatment of cancer

placeNew York City, New York, United States calendar_todayFounded 2010 groups17 employees language promontorytx.com

Registered entities

Innovation

3 patent families (2 granted) — focus: Human necessities, Physics & computing; filing pace steady. Cited 15 times.

YearFilings
20221
20233
20242
20251

Social engagement

Social engagement: 2.7K social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record; lead investors include Adinvest.

Investor typeCountShare
Venture capital150%
Angel & family office150%

Recent activity

8 Apr 2026
Event
Groon Research Conferences 2026
29 Oct 2025
Event
cphi
Coming soon